This Finnish population-based study, mean age 46 years, evaluates the association of high-sensitivity C-reactive protein (hs-CRP), interleukin-1 receptor antagonist (IL-1Ra), andadiponectin with the NCEP and IDF definitions of metabolicsyndrome (MetS). Here, CRP is linked to metabolic syndrome.